BridgeBio Oncology Therapeutics Inc. (BBOT) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

BridgeBio Oncology Therapeutics Inc. (BBOT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $673.7M, listed on NASDAQ, employing roughly 92 people, carrying a beta of 0.39 to the broader market. BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. Led by Pedro J. Beltran, public since 2025-08-12.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for BBOT as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →